| View |
|
DR-XY20290-B
|
Cefalexin (As Monohydrate)
|
Vicephrin
|
250 mg/5 mL
|
Powder For Suspension
|
-
|
Lloyd Laboratories, Inc.
|
Philippines
|
-
|
18 June 2020
|
23 May 2025
|
| View |
|
DR-XY20310
|
Salbutamol (As Sulfate)
|
None
|
2 mg
|
Tablet
|
-
|
Fortis Medi Pharmaceutical, Inc.
|
Philippines
|
-
|
08 October 2019
|
24 October 2024
|
| View |
|
DR-XY20336-B
|
Cloxacillin (As Sodium)
|
Vamcloxil
|
500 mg
|
Capsule
|
Antibacterials
|
Lloyd Laboratories, Inc.
|
Philippines
|
Renewal
|
15 June 2022
|
29 July 2027
|
| View |
|
DR-XY20356
|
Paracetamol
|
None
|
500mg
|
Tablet
|
Analgesic / Antipyretic
|
Fortis Medi Pharmaceuticals, Inc.
|
Philippines
|
Automatic Renewal
|
21 July 2021
|
14 September 2026
|
| View |
|
DR-XY20374
|
Epinephrine (As Hydrochloride)
|
None
|
1 mg/mL (0.1%w/v)
|
Solution For Injection (I.M./S.C./I.V.)
|
-
|
Ciron Drugs & Pharmaceuticals Pvt., Limited
|
India
|
-
|
26 February 2021
|
25 September 2025
|
| View |
|
DR-XY20374-B
|
Epinephrine (As Hydrochoride)
|
Adrenin
|
1mg/mL (0.1%w/v)
|
Solution For Injection
|
Adrenergic Agent
|
Oboi Laboratories
|
India
|
Automatic Renewal
|
28 February 2023
|
11 July 2028
|
| View |
|
DR-XY20382-B
|
Cotrimoxazole
|
Procor
|
200 mg/40 mg per 5 mL
|
Suspension
|
Antibacterial (Sulfonamide)
|
Lloyd Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
28 November 2022
|
15 December 2027
|
| View |
|
DR-XY20418-B
|
Thiamine Mononitrate (Vitamin B1)+Pyridoxine Hydrochloride (Vitamin B6)+Cyanocobalamin (Vitamin B12)
|
Neurobase
|
100 mg/5 mg/50 mcg
|
Capsule
|
-
|
Lloyd Laboratories, Inc.
|
Philippines
|
-
|
17 February 2020
|
23 February 2025
|
| View |
|
DR-XY20446
|
Tramadol Hydrochloride
|
Siverol
|
50 mg
|
Capsule
|
Opioid Analgesic
|
Amherst Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
11 November 2022
|
21 December 2027
|
| View |
|
DR-XY20477
|
Indomethacin
|
Vi-Gel
|
10 mg/g (1% w/w)
|
Topical Cream
|
-
|
Cho Dang Pharmaceutical Co., Ltd.
|
Korea
|
Renewal
|
09 March 2023
|
18 October 2027
|
| View |
|
DR-XY20480
|
Cefalexin (As Monohydrate)
|
Nerfalex
|
500 mg
|
Capsule
|
Antibacterial (Cephalosporin)
|
Lloyd Laboratories Inc.
|
Philippines
|
Automatic Renewal
|
24 September 2022
|
23 October 2027
|
| View |
|
DR-XY20491
|
Furosemide
|
Furix
|
40 mg
|
Tablet
|
Anticongestive Heart Failure/Diuretics
|
Lloyd Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
07 July 2023
|
20 October 2028
|
| View |
|
DR-XY20496-B
|
Cotrimoxazole
|
Primecotrix
|
200 mg/40 mg per 5 mL
|
Suspension
|
Antibacterial
|
Lloyd Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
26 October 2021
|
28 November 2026
|
| View |
|
DR-XY20500
|
Salbutamol (As Sulfate)
|
Amoltex
|
2mg/5 mL
|
Syrup
|
Selective Beta-2-Adrenoreceptor Agonist
|
Lloyd Laboratores, Inc.
|
Philippines
|
Automatic Renewal
|
04 October 2022
|
19 October 2027
|
| View |
|
DR-XY20534
|
Antiox
|
Mebendazole
|
50 mg/mL
|
Oral Suspension (Choco Flavor)
|
-
|
Interphil Laboratories, Inc.
|
Philippines
|
-
|
18 February 2021
|
08 November 2025
|
| View |
|
DR-XY20542
|
Potassium Citrate
|
Acalka
|
1080 mg (10 mEq)
|
Prolonged-Release Tablet
|
Antiurolithic
|
Ferrer International, S.A.
|
Spain
|
Renewal
|
10 June 2024
|
17 December 2029
|
| View |
|
DR-XY20552-B
|
Cloxacillin (as Sodium Monohydrate)
|
Axillin
|
250mg
|
Capsule
|
Antibacterial (Penicillin
|
Lloyd Laboratories, Inc.
|
Philippines
|
Automatic Renewal (Revalidation)
|
14 January 2022
|
11 March 2027
|
| View |
DR-XY20557_PI_01.pdf
|
DR-XY20557
|
Desferrioxamine mesilate
|
Desferal
|
500mg
|
Powder for Injection (IM/IV/SC)
|
Iron-chelating agent
|
Wasserburger Arzneimittelwerk GmbH
|
Germany
|
Automatic Renewal
|
03 November 2021
|
27 September 2026
|
| View |
|
DR-XY20605
|
Cefalexin (As Monohydrate)
|
Cendalex
|
250 mg/5 mL
|
Powder For Suspension
|
Antibacterial (Cephalosporin)
|
Lloyd Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
28 November 2022
|
06 December 2027
|
| View |
|
DR-XY20680
|
Ginkgo Biloba EGb 761
|
Tebokan
|
40mg
|
Film Coated Tablet
|
Neurotropic Agent
|
Dr. Willmar Schwabe GmbH & Co. KG
|
Germany
|
Initial (from Monitored Release Extension)
|
27 April 2022
|
24 April 2025
|